We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Market Edge Highlights: Amazon, Chipotle, Lululemon, VOO, and QQQ
Read MoreHide Full Article
For Immediate Release
Chicago, IL – October 28, 2021 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:
Can You Get Rich Off Basic Stock Index ETFs?
Welcome to Episode #290 of the Zacks Market Edge Podcast.
(1:00) - Are You Better Off Buying Index Funds vs. Individual Stocks?
(7:20) - Breaking Down The Performance of Index ETFs: Which One Is Right For You?
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
This week, Tracey is going to solo to talk about investing in the basic stock index ETFs.
Many investors get frustrated by their lack of investing choices in their 401ks, where there are usually basic stock index funds and ETFs. For some, investing in individual stocks are the only way to build wealth quickly.
But can you get rich off of owning the basic stock index ETFs?
Are You Beating the S&P 500?
Over the last year, the S&P 500 has hit new highs and has gained 32%.
That’s a pretty hefty return, for any investment. Are you sure your favorite growth stocks are out performing it?
Amazon (AMZN - Free Report) is up just 5.4% over the last year, even though it soared during the initial months of the pandemic.
Even mighty Chipotle (CMG - Free Report) , which has busted out to new all-time highs this year, is up “just” 31% in the last year.
Similarly, one of the hottest retailers on the Street, Lululemon (LULU - Free Report) has gained “only” 28.9% over the last year.
Other hot stocks have certainly outperformed, including Tesla and Shopify, but it may not be as easy to “beat” the index as you think, especially when the index is seeing big gains.
The S&P 500 and the Nasdaq-100 ETFs: Boring?
Investing in the S&P 500 may seem “boring” but during bull markets it can be anything but.
The Vanguard S&P 500 ETF (VOO - Free Report) has a 10-year annualized return of 16.5%. $10,000 invested in Sep 2011 was $46,426 by Sep 2021.
But the INVESCO QQQ ETF (QQQ - Free Report) , which tracks the Nasdaq 100, is even hotter. This “boring” index ETF has a 10-year annualized return of 21.25%.
$10,000 invested in Sep 2011 in the QQQ was $66,107 by Sep 2021.
What else do you need to know about using the stock index ETFs to grow your wealth?
Tune into this podcast to find out.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Market Edge Highlights: Amazon, Chipotle, Lululemon, VOO, and QQQ
For Immediate Release
Chicago, IL – October 28, 2021 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:
Can You Get Rich Off Basic Stock Index ETFs?
Welcome to Episode #290 of the Zacks Market Edge Podcast.
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
This week, Tracey is going to solo to talk about investing in the basic stock index ETFs.
Many investors get frustrated by their lack of investing choices in their 401ks, where there are usually basic stock index funds and ETFs. For some, investing in individual stocks are the only way to build wealth quickly.
But can you get rich off of owning the basic stock index ETFs?
Are You Beating the S&P 500?
Over the last year, the S&P 500 has hit new highs and has gained 32%.
That’s a pretty hefty return, for any investment. Are you sure your favorite growth stocks are out performing it?
Amazon (AMZN - Free Report) is up just 5.4% over the last year, even though it soared during the initial months of the pandemic.
Even mighty Chipotle (CMG - Free Report) , which has busted out to new all-time highs this year, is up “just” 31% in the last year.
Similarly, one of the hottest retailers on the Street, Lululemon (LULU - Free Report) has gained “only” 28.9% over the last year.
Other hot stocks have certainly outperformed, including Tesla and Shopify, but it may not be as easy to “beat” the index as you think, especially when the index is seeing big gains.
The S&P 500 and the Nasdaq-100 ETFs: Boring?
Investing in the S&P 500 may seem “boring” but during bull markets it can be anything but.
The Vanguard S&P 500 ETF (VOO - Free Report) has a 10-year annualized return of 16.5%. $10,000 invested in Sep 2011 was $46,426 by Sep 2021.
But the INVESCO QQQ ETF (QQQ - Free Report) , which tracks the Nasdaq 100, is even hotter. This “boring” index ETF has a 10-year annualized return of 21.25%.
$10,000 invested in Sep 2011 in the QQQ was $66,107 by Sep 2021.
What else do you need to know about using the stock index ETFs to grow your wealth?
Tune into this podcast to find out.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.